

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma secretion (GO:0072643) | 4.82658450 |
| 2 | parturition (GO:0007567) | 4.61249122 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.45418935 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.44454051 |
| 5 | DNA deamination (GO:0045006) | 4.28856487 |
| 6 | sulfation (GO:0051923) | 4.02160235 |
| 7 | activated T cell proliferation (GO:0050798) | 3.96841966 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.96226446 |
| 9 | regulation of cell communication by electrical coupling (GO:0010649) | 3.86098588 |
| 10 | regulation of germinal center formation (GO:0002634) | 3.83096205 |
| 11 | myofibril assembly (GO:0030239) | 3.80001653 |
| 12 | * regulation of skeletal muscle contraction (GO:0014819) | 3.79813038 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.78864699 |
| 14 | regulation of DNA endoreduplication (GO:0032875) | 3.78145021 |
| 15 | cellular response to exogenous dsRNA (GO:0071360) | 3.77654733 |
| 16 | regulation of sarcomere organization (GO:0060297) | 3.63292188 |
| 17 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.57970167 |
| 18 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.57970167 |
| 19 | NADH dehydrogenase complex assembly (GO:0010257) | 3.57970167 |
| 20 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.56264357 |
| 21 | cardiac myofibril assembly (GO:0055003) | 3.52684829 |
| 22 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.51588408 |
| 23 | positive regulation of synapse maturation (GO:0090129) | 3.47818308 |
| 24 | muscle filament sliding (GO:0030049) | 3.44116504 |
| 25 | actin-myosin filament sliding (GO:0033275) | 3.44116504 |
| 26 | regulation of mesoderm development (GO:2000380) | 3.43397844 |
| 27 | response to xenobiotic stimulus (GO:0009410) | 3.42971461 |
| 28 | cell proliferation in forebrain (GO:0021846) | 3.37960646 |
| 29 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.29306732 |
| 30 | regulation of synapse maturation (GO:0090128) | 3.29256626 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.28143707 |
| 32 | sarcomere organization (GO:0045214) | 3.26758067 |
| 33 | cellular response to electrical stimulus (GO:0071257) | 3.26549565 |
| 34 | cellular anion homeostasis (GO:0030002) | 3.26506848 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23037606 |
| 36 | response to electrical stimulus (GO:0051602) | 3.22151807 |
| 37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.22035704 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19870155 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.19870155 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19870155 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19870155 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19870155 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.19870155 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.19423641 |
| 45 | regulation of relaxation of muscle (GO:1901077) | 3.18647383 |
| 46 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.16369949 |
| 47 | cardiovascular system development (GO:0072358) | 3.15418515 |
| 48 | vitamin catabolic process (GO:0009111) | 3.12361202 |
| 49 | fat-soluble vitamin catabolic process (GO:0042363) | 3.12361202 |
| 50 | protein complex biogenesis (GO:0070271) | 3.12086866 |
| 51 | ovulation cycle (GO:0042698) | 3.07956609 |
| 52 | regulation of actin filament-based movement (GO:1903115) | 3.04011950 |
| 53 | plasma membrane repair (GO:0001778) | 3.04011479 |
| 54 | regulation of glomerulus development (GO:0090192) | 2.96150068 |
| 55 | actin-mediated cell contraction (GO:0070252) | 2.95770712 |
| 56 | T cell mediated immunity (GO:0002456) | 2.94480571 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 2.92050649 |
| 58 | dentate gyrus development (GO:0021542) | 2.90283402 |
| 59 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.83530656 |
| 60 | retinal ganglion cell axon guidance (GO:0031290) | 2.81736672 |
| 61 | negative regulation of appetite (GO:0032099) | 2.79704762 |
| 62 | negative regulation of response to food (GO:0032096) | 2.79704762 |
| 63 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75647409 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73347731 |
| 65 | skeletal muscle contraction (GO:0003009) | 2.72384877 |
| 66 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.72355091 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 2.71910831 |
| 68 | cellular response to ATP (GO:0071318) | 2.71359959 |
| 69 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.67665750 |
| 70 | cardiac muscle hypertrophy (GO:0003300) | 2.67372346 |
| 71 | actomyosin structure organization (GO:0031032) | 2.66833711 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 2.66044772 |
| 73 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.65408028 |
| 74 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.65408028 |
| 75 | negative regulation of protein localization to cell surface (GO:2000009) | 2.64818766 |
| 76 | serotonin metabolic process (GO:0042428) | 2.64639034 |
| 77 | skeletal muscle adaptation (GO:0043501) | 2.64600702 |
| 78 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.63709397 |
| 79 | * regulation of striated muscle contraction (GO:0006942) | 2.63643935 |
| 80 | negative regulation of mast cell activation (GO:0033004) | 2.63252317 |
| 81 | actin filament-based movement (GO:0030048) | 2.63119761 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.62745445 |
| 83 | interkinetic nuclear migration (GO:0022027) | 2.62647089 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.61936082 |
| 85 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.61571658 |
| 86 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.60327953 |
| 87 | striated muscle contraction (GO:0006941) | 2.59240717 |
| 88 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.56986109 |
| 89 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.56586728 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.56391194 |
| 91 | cardiac muscle contraction (GO:0060048) | 2.55513228 |
| 92 | striated muscle hypertrophy (GO:0014897) | 2.55161319 |
| 93 | * relaxation of cardiac muscle (GO:0055119) | 2.54995414 |
| 94 | endoderm formation (GO:0001706) | 2.54879428 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 2.54699360 |
| 96 | alkaloid metabolic process (GO:0009820) | 2.54155215 |
| 97 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.54075808 |
| 98 | microglial cell activation (GO:0001774) | 2.51709170 |
| 99 | muscle hypertrophy (GO:0014896) | 2.50421741 |
| 100 | * regulation of membrane repolarization (GO:0060306) | 2.50272545 |
| 101 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.49463564 |
| 102 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.49463564 |
| 103 | somite development (GO:0061053) | 2.48613134 |
| 104 | interferon-gamma production (GO:0032609) | 2.48308998 |
| 105 | adaptation of signaling pathway (GO:0023058) | 2.47785593 |
| 106 | neutrophil mediated immunity (GO:0002446) | 2.47641438 |
| 107 | positive regulation of meiosis (GO:0045836) | 2.47377357 |
| 108 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46870430 |
| 109 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.46728416 |
| 110 | protein polyglutamylation (GO:0018095) | 2.46259169 |
| 111 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.46164866 |
| 112 | detection of light stimulus involved in visual perception (GO:0050908) | 2.46164866 |
| 113 | negative regulation of fatty acid transport (GO:2000192) | 2.46003142 |
| 114 | epithelial cell fate commitment (GO:0072148) | 2.44325196 |
| 115 | flavonoid metabolic process (GO:0009812) | 2.43898551 |
| 116 | indolalkylamine metabolic process (GO:0006586) | 2.43242185 |
| 117 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.41917182 |
| 118 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.41810451 |
| 119 | regulation of cardiac muscle contraction (GO:0055117) | 2.41643018 |
| 120 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41481983 |
| 121 | response to host immune response (GO:0052572) | 2.41481983 |
| 122 | negative regulation of ERK1 and ERK2 cascade (GO:0070373) | 2.41314607 |
| 123 | response to peptidoglycan (GO:0032494) | 2.40423463 |
| 124 | positive regulation of cation channel activity (GO:2001259) | 2.40393061 |
| 125 | response to inactivity (GO:0014854) | 2.39982199 |
| 126 | neuronal action potential (GO:0019228) | 2.39831627 |
| 127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.38820735 |
| 128 | chemical homeostasis within a tissue (GO:0048875) | 2.38598428 |
| 129 | primary amino compound metabolic process (GO:1901160) | 2.38077955 |
| 130 | prostate gland growth (GO:0060736) | 2.38046724 |
| 131 | monocyte chemotaxis (GO:0002548) | 2.37613488 |
| 132 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.36942483 |
| 133 | * cardiac conduction (GO:0061337) | 2.36705419 |
| 134 | L-amino acid import (GO:0043092) | 2.35129189 |
| 135 | dendritic spine morphogenesis (GO:0060997) | 2.35017219 |
| 136 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.31120757 |
| 137 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.31050601 |
| 138 | positive regulation of meiotic cell cycle (GO:0051446) | 2.30371909 |
| 139 | detection of calcium ion (GO:0005513) | 2.28507916 |
| 140 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.27429393 |
| 141 | surfactant homeostasis (GO:0043129) | 2.26971156 |
| 142 | striated muscle atrophy (GO:0014891) | 2.26557805 |
| 143 | * regulation of potassium ion transmembrane transport (GO:1901379) | 2.25924650 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.25610544 |
| 145 | response to caffeine (GO:0031000) | 2.25521150 |
| 146 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.25002463 |
| 147 | cAMP catabolic process (GO:0006198) | 2.24922709 |
| 148 | regulation of sequestering of triglyceride (GO:0010889) | 2.24724579 |
| 149 | regulation of cation channel activity (GO:2001257) | 2.24412578 |
| 150 | synaptic transmission, cholinergic (GO:0007271) | 2.24006094 |
| 151 | response to host defenses (GO:0052200) | 2.23692023 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.23692023 |
| 153 | response to host (GO:0075136) | 2.23692023 |
| 154 | positive regulation of interferon-alpha production (GO:0032727) | 2.23538314 |
| 155 | cytidine metabolic process (GO:0046087) | 2.22773077 |
| 156 | cytidine catabolic process (GO:0006216) | 2.22773077 |
| 157 | cytidine deamination (GO:0009972) | 2.22773077 |
| 158 | regulation of interferon-alpha production (GO:0032647) | 2.22724497 |
| 159 | segment specification (GO:0007379) | 2.22172142 |
| 160 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.20555103 |
| 161 | glandular epithelial cell differentiation (GO:0002067) | 2.18985386 |
| 162 | indole-containing compound catabolic process (GO:0042436) | 2.17962851 |
| 163 | indolalkylamine catabolic process (GO:0046218) | 2.17962851 |
| 164 | tryptophan catabolic process (GO:0006569) | 2.17962851 |
| 165 | pharyngeal system development (GO:0060037) | 2.17696611 |
| 166 | striated muscle adaptation (GO:0014888) | 2.17044439 |
| 167 | muscle adaptation (GO:0043500) | 2.16924908 |
| 168 | striatum development (GO:0021756) | 2.16203212 |
| 169 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.16029053 |
| 170 | negative regulation of sodium ion transport (GO:0010766) | 2.15681353 |
| 171 | macrophage activation (GO:0042116) | 2.15567667 |
| 172 | positive regulation of heat generation (GO:0031652) | 2.15508790 |
| 173 | regulation of action potential (GO:0098900) | 2.15319169 |
| 174 | heart trabecula formation (GO:0060347) | 2.14706155 |
| 175 | replicative senescence (GO:0090399) | 2.14215390 |
| 176 | positive regulation of macrophage cytokine production (GO:0060907) | 2.14020875 |
| 177 | regulation of heat generation (GO:0031650) | 2.13813561 |
| 178 | cytokine secretion (GO:0050663) | 2.13590952 |
| 179 | substrate-dependent cell migration (GO:0006929) | 2.13546472 |
| 180 | spinal cord motor neuron differentiation (GO:0021522) | 2.13255844 |
| 181 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.12672512 |
| 182 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.10690953 |
| 183 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.10660121 |
| 184 | ganglion development (GO:0061548) | 2.10485838 |
| 185 | cyclic nucleotide catabolic process (GO:0009214) | 2.09206207 |
| 186 | muscle atrophy (GO:0014889) | 2.08545804 |
| 187 | import into cell (GO:0098657) | 2.06719886 |
| 188 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.06258347 |
| 189 | adrenergic receptor signaling pathway (GO:0071875) | 2.05888588 |
| 190 | G-protein coupled receptor internalization (GO:0002031) | 2.05079797 |
| 191 | cell communication involved in cardiac conduction (GO:0086065) | 2.04962419 |
| 192 | regulation of p38MAPK cascade (GO:1900744) | 2.03841820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.93292128 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.58761672 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61614069 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.56156769 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.45052230 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.31085771 |
| 7 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.01935217 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01531219 |
| 9 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96790489 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.95800998 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95796706 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88130490 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.84441196 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81662154 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78836823 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75925278 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.74947641 |
| 18 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73601894 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.72780167 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.71328855 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70140589 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67457028 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64125875 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64125875 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63059688 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61317236 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55231862 |
| 28 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55069372 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.54381673 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53475269 |
| 31 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53142473 |
| 32 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53142473 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52709642 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52148851 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51653651 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50366638 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.48554201 |
| 38 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.47882629 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47255196 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46943442 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46783234 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46477243 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45867911 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43891959 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42114459 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40670661 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40642962 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39827568 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39403815 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39364272 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39205780 |
| 52 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39110421 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39005042 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38141649 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36120893 |
| 56 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35305665 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35152908 |
| 58 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32217720 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31457528 |
| 60 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31350558 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30299338 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30054427 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29365137 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.29365137 |
| 65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29347435 |
| 66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29125205 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27928796 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27794938 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27269753 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27164551 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25181074 |
| 72 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24904808 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23891873 |
| 74 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23612507 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23117449 |
| 76 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23074234 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22843072 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22411477 |
| 79 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21450844 |
| 80 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20395829 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19857203 |
| 82 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17834409 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17611887 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17611887 |
| 85 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16858767 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.16758085 |
| 87 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.15242412 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15163746 |
| 89 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13563930 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12444757 |
| 91 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.12405936 |
| 92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12382473 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12382473 |
| 94 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.12115544 |
| 95 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11637707 |
| 96 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10404126 |
| 97 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10219416 |
| 98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07820919 |
| 99 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07439810 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06969729 |
| 101 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05646367 |
| 102 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05534058 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04608007 |
| 104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04608007 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03128181 |
| 106 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02492246 |
| 107 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02281148 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02180273 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 1.01265845 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00409679 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00162885 |
| 112 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99883977 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99745023 |
| 114 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99491665 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98908056 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98827315 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98505958 |
| 118 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98488598 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98091163 |
| 120 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97423796 |
| 121 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97036524 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96518754 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96517895 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96512783 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95768880 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95414439 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94490028 |
| 128 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.94430772 |
| 129 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93918647 |
| 130 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93918647 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93849984 |
| 132 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93788426 |
| 133 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93672392 |
| 134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93296954 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93211589 |
| 136 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92733172 |
| 137 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92588142 |
| 138 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90628275 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90585538 |
| 140 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89567928 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88317888 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87901970 |
| 143 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87386383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.38853633 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.25378720 |
| 3 | MP0003646_muscle_fatigue | 3.21240603 |
| 4 | MP0003724_increased_susceptibility_to | 3.18504114 |
| 5 | MP0004885_abnormal_endolymph | 3.07249065 |
| 6 | MP0000749_muscle_degeneration | 3.01444302 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.98816200 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.85372297 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.85073035 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.81177781 |
| 11 | MP0004484_altered_response_of | 2.51682629 |
| 12 | MP0003690_abnormal_glial_cell | 2.44971809 |
| 13 | MP0004130_abnormal_muscle_cell | 2.39472890 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.38097074 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.37452188 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.27024243 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.24007137 |
| 18 | MP0004087_abnormal_muscle_fiber | 2.15997666 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.15077029 |
| 20 | MP0002160_abnormal_reproductive_system | 2.12936490 |
| 21 | MP0004510_myositis | 2.11862039 |
| 22 | MP0005330_cardiomyopathy | 2.06851559 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 2.03262455 |
| 24 | MP0002638_abnormal_pupillary_reflex | 2.01288756 |
| 25 | MP0002106_abnormal_muscle_physiology | 1.99269681 |
| 26 | MP0005389_reproductive_system_phenotype | 1.98829249 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.96286058 |
| 28 | MP0003787_abnormal_imprinting | 1.95072559 |
| 29 | MP0003828_pulmonary_edema | 1.94660195 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.92963755 |
| 31 | MP0003283_abnormal_digestive_organ | 1.92770631 |
| 32 | MP0003011_delayed_dark_adaptation | 1.92323737 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.92189575 |
| 34 | MP0005671_abnormal_response_to | 1.84539099 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.77771501 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.76921456 |
| 37 | MP0004142_abnormal_muscle_tone | 1.76279752 |
| 38 | MP0002822_catalepsy | 1.76251473 |
| 39 | MP0002272_abnormal_nervous_system | 1.76002584 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.75551118 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.74247158 |
| 42 | MP0005171_absent_coat_pigmentation | 1.73441878 |
| 43 | MP0005369_muscle_phenotype | 1.69814267 |
| 44 | MP0006082_CNS_inflammation | 1.68794831 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.68107910 |
| 46 | MP0000920_abnormal_myelination | 1.68013448 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.67371811 |
| 48 | MP0005385_cardiovascular_system_phenoty | 1.67371811 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.66300503 |
| 50 | MP0003303_peritoneal_inflammation | 1.65669795 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.64469120 |
| 52 | MP0006138_congestive_heart_failure | 1.58967335 |
| 53 | MP0003137_abnormal_impulse_conducting | 1.57363243 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.56738454 |
| 55 | MP0003879_abnormal_hair_cell | 1.55595721 |
| 56 | MP0000631_abnormal_neuroendocrine_gland | 1.55094524 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.52158468 |
| 58 | MP0004085_abnormal_heartbeat | 1.51288750 |
| 59 | MP0000759_abnormal_skeletal_muscle | 1.51110403 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.49837143 |
| 61 | MP0002163_abnormal_gland_morphology | 1.49646115 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.48856907 |
| 63 | MP0003075_altered_response_to | 1.47978222 |
| 64 | MP0000747_muscle_weakness | 1.41221596 |
| 65 | MP0009764_decreased_sensitivity_to | 1.40983911 |
| 66 | MP0003195_calcinosis | 1.35289693 |
| 67 | MP0000049_abnormal_middle_ear | 1.34956119 |
| 68 | MP0000685_abnormal_immune_system | 1.32496817 |
| 69 | MP0000343_altered_response_to | 1.31574876 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.29926213 |
| 71 | MP0001919_abnormal_reproductive_system | 1.28814586 |
| 72 | MP0002419_abnormal_innate_immunity | 1.26994258 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.26516878 |
| 74 | MP0001486_abnormal_startle_reflex | 1.26353673 |
| 75 | MP0004742_abnormal_vestibular_system | 1.26044204 |
| 76 | MP0001958_emphysema | 1.25761326 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.25731404 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.25292738 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.25043793 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.25018541 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.22714206 |
| 82 | MP0004133_heterotaxia | 1.22482639 |
| 83 | MP0002653_abnormal_ependyma_morphology | 1.22260459 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.22066714 |
| 85 | MP0001851_eye_inflammation | 1.21233245 |
| 86 | MP0002102_abnormal_ear_morphology | 1.20683523 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 1.18765619 |
| 88 | MP0008004_abnormal_stomach_pH | 1.18603710 |
| 89 | MP0009785_altered_susceptibility_to | 1.18600894 |
| 90 | MP0003633_abnormal_nervous_system | 1.17946579 |
| 91 | MP0004270_analgesia | 1.17863438 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.17148587 |
| 93 | MP0005409_darkened_coat_color | 1.16943460 |
| 94 | MP0000733_abnormal_muscle_development | 1.16614311 |
| 95 | MP0001800_abnormal_humoral_immune | 1.16489168 |
| 96 | MP0000230_abnormal_systemic_arterial | 1.16263211 |
| 97 | MP0003300_gastrointestinal_ulcer | 1.15996867 |
| 98 | MP0001970_abnormal_pain_threshold | 1.15093074 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 1.14806328 |
| 100 | MP0005253_abnormal_eye_physiology | 1.14269225 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.12569587 |
| 102 | MP0002090_abnormal_vision | 1.12478011 |
| 103 | MP0008872_abnormal_physiological_respon | 1.12118469 |
| 104 | MP0004134_abnormal_chest_morphology | 1.10445020 |
| 105 | MP0009745_abnormal_behavioral_response | 1.08669824 |
| 106 | MP0005166_decreased_susceptibility_to | 1.06985435 |
| 107 | MP0003880_abnormal_central_pattern | 1.05160025 |
| 108 | MP0003045_fibrosis | 1.04467000 |
| 109 | MP0002064_seizures | 1.04171527 |
| 110 | MP0004147_increased_porphyrin_level | 1.03905934 |
| 111 | MP0001905_abnormal_dopamine_level | 1.02505098 |
| 112 | MP0002133_abnormal_respiratory_system | 1.02205901 |
| 113 | MP0005388_respiratory_system_phenotype | 1.02205901 |
| 114 | MP0005165_increased_susceptibility_to | 1.01798685 |
| 115 | MP0002998_abnormal_bone_remodeling | 1.01146467 |
| 116 | MP0002928_abnormal_bile_duct | 1.00161832 |
| 117 | MP0003121_genomic_imprinting | 1.00061840 |
| 118 | MP0003436_decreased_susceptibility_to | 0.99018454 |
| 119 | MP0009379_abnormal_foot_pigmentation | 0.98156644 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.97873854 |
| 121 | MP0002572_abnormal_emotion/affect_behav | 0.97014206 |
| 122 | MP0001790_abnormal_immune_system | 0.96833486 |
| 123 | MP0005387_immune_system_phenotype | 0.96833486 |
| 124 | MP0001188_hyperpigmentation | 0.96337187 |
| 125 | MP0003635_abnormal_synaptic_transmissio | 0.94723798 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.94325942 |
| 127 | MP0002736_abnormal_nociception_after | 0.93369388 |
| 128 | MP0001542_abnormal_bone_strength | 0.93320439 |
| 129 | MP0009046_muscle_twitch | 0.93176116 |
| 130 | MP0008438_abnormal_cutaneous_collagen | 0.92610276 |
| 131 | MP0002269_muscular_atrophy | 0.90248706 |
| 132 | MP0002067_abnormal_sensory_capabilities | 0.90205820 |
| 133 | MP0000026_abnormal_inner_ear | 0.90084837 |
| 134 | MP0001533_abnormal_skeleton_physiology | 0.89958064 |
| 135 | MP0001984_abnormal_olfaction | 0.89931245 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.89259826 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.88935746 |
| 138 | MP0009250_abnormal_appendicular_skeleto | 0.87849234 |
| 139 | MP0006276_abnormal_autonomic_nervous | 0.86829084 |
| 140 | MP0002938_white_spotting | 0.86300060 |
| 141 | MP0002723_abnormal_immune_serum | 0.84105941 |
| 142 | MP0001177_atelectasis | 0.84075733 |
| 143 | MP0003566_abnormal_cell_adhesion | 0.83975284 |
| 144 | MP0003634_abnormal_glial_cell | 0.83929917 |
| 145 | MP0002063_abnormal_learning/memory/cond | 0.83492891 |
| 146 | MP0003279_aneurysm | 0.83252560 |
| 147 | MP0005423_abnormal_somatic_nervous | 0.81965960 |
| 148 | MP0000767_abnormal_smooth_muscle | 0.81107813 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.80523849 |
| 150 | MP0005000_abnormal_immune_tolerance | 0.80428308 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.80189382 |
| 152 | MP0002148_abnormal_hypersensitivity_rea | 0.79957118 |
| 153 | MP0010368_abnormal_lymphatic_system | 0.79760727 |
| 154 | MP0002452_abnormal_antigen_presenting | 0.79739044 |
| 155 | MP0005195_abnormal_posterior_eye | 0.79612546 |
| 156 | MP0005386_behavior/neurological_phenoty | 0.78092847 |
| 157 | MP0004924_abnormal_behavior | 0.78092847 |
| 158 | MP0001963_abnormal_hearing_physiology | 0.77942671 |
| 159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77922395 |
| 160 | MP0000383_abnormal_hair_follicle | 0.76814202 |
| 161 | MP0002557_abnormal_social/conspecific_i | 0.76645030 |
| 162 | MP0002734_abnormal_mechanical_nocicepti | 0.76476501 |
| 163 | MP0001501_abnormal_sleep_pattern | 0.76268527 |
| 164 | MP0003938_abnormal_ear_development | 0.75872500 |
| 165 | MP0000470_abnormal_stomach_morphology | 0.74473594 |
| 166 | MP0004782_abnormal_surfactant_physiolog | 0.74347669 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.73025381 |
| 168 | MP0001440_abnormal_grooming_behavior | 0.72593004 |
| 169 | MP0001663_abnormal_digestive_system | 0.72531190 |
| 170 | MP0004185_abnormal_adipocyte_glucose | 0.71670363 |
| 171 | MP0003631_nervous_system_phenotype | 0.71662202 |
| 172 | MP0009278_abnormal_bone_marrow | 0.70966384 |
| 173 | MP0004233_abnormal_muscle_weight | 0.69320745 |
| 174 | MP0001299_abnormal_eye_distance/ | 0.69236522 |
| 175 | MP0005666_abnormal_adipose_tissue | 0.66596515 |
| 176 | MP0005623_abnormal_meninges_morphology | 0.63903953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 5.73746788 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.31297684 |
| 3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.07224414 |
| 4 | Sudden death (HP:0001699) | 5.04530809 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.83794245 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.36601311 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.28395091 |
| 8 | * Atrial fibrillation (HP:0005110) | 4.21256253 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.15287909 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 3.91424110 |
| 11 | * Primary atrial arrhythmia (HP:0001692) | 3.87725663 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 3.87449086 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 3.82788953 |
| 14 | Nemaline bodies (HP:0003798) | 3.77807431 |
| 15 | Ventricular tachycardia (HP:0004756) | 3.69184773 |
| 16 | Osteomalacia (HP:0002749) | 3.62807632 |
| 17 | * Supraventricular tachycardia (HP:0004755) | 3.58051726 |
| 18 | Decreased circulating renin level (HP:0003351) | 3.52004352 |
| 19 | * Supraventricular arrhythmia (HP:0005115) | 3.50631670 |
| 20 | Axonal loss (HP:0003447) | 3.49305024 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.45112954 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.39924815 |
| 23 | Difficulty running (HP:0009046) | 3.39221729 |
| 24 | Prolonged QT interval (HP:0001657) | 3.38171008 |
| 25 | Pancreatic cysts (HP:0001737) | 3.37707324 |
| 26 | Subaortic stenosis (HP:0001682) | 3.35995640 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.35995640 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.33568065 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.32774431 |
| 30 | Conjunctival hamartoma (HP:0100780) | 3.27437497 |
| 31 | Nephronophthisis (HP:0000090) | 3.21387807 |
| 32 | Congenital, generalized hypertrichosis (HP:0004540) | 3.21339576 |
| 33 | * Syncope (HP:0001279) | 3.19833026 |
| 34 | Congenital stationary night blindness (HP:0007642) | 3.17779293 |
| 35 | Progressive cerebellar ataxia (HP:0002073) | 3.12220000 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.11376526 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.11257077 |
| 38 | Clumsiness (HP:0002312) | 3.08900788 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 3.07695243 |
| 40 | Bundle branch block (HP:0011710) | 3.05947878 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 3.03937564 |
| 42 | Increased connective tissue (HP:0009025) | 3.02882632 |
| 43 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.00920903 |
| 44 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.98882703 |
| 45 | True hermaphroditism (HP:0010459) | 2.97986633 |
| 46 | Short femoral neck (HP:0100864) | 2.97810161 |
| 47 | Genetic anticipation (HP:0003743) | 2.93848474 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.88636178 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.88636178 |
| 50 | Lipoatrophy (HP:0100578) | 2.87452315 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.84257401 |
| 52 | Thick nail (HP:0001805) | 2.84155313 |
| 53 | Asplenia (HP:0001746) | 2.81590737 |
| 54 | Abnormality of the renal medulla (HP:0100957) | 2.77663714 |
| 55 | Lower limb amyotrophy (HP:0007210) | 2.75829556 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.74793442 |
| 57 | Short hallux (HP:0010109) | 2.73641452 |
| 58 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.72359356 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.68145268 |
| 60 | Heart block (HP:0012722) | 2.66932160 |
| 61 | Anomalous pulmonary venous return (HP:0010772) | 2.64626816 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.64492486 |
| 63 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.63483682 |
| 64 | Furrowed tongue (HP:0000221) | 2.62966159 |
| 65 | Myotonia (HP:0002486) | 2.62068334 |
| 66 | Myoglobinuria (HP:0002913) | 2.61402575 |
| 67 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.61220911 |
| 68 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.61194641 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57067443 |
| 70 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.56142134 |
| 71 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55902876 |
| 72 | Abnormal atrioventricular conduction (HP:0005150) | 2.54002652 |
| 73 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.52449538 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.52319741 |
| 75 | Adactyly (HP:0009776) | 2.52128185 |
| 76 | Megalencephaly (HP:0001355) | 2.51391350 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.50649674 |
| 78 | Abnormality of the pulmonary veins (HP:0011718) | 2.50381663 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 2.47634608 |
| 80 | Hemiplegia (HP:0002301) | 2.46333546 |
| 81 | Muscle stiffness (HP:0003552) | 2.45893700 |
| 82 | Short 1st metacarpal (HP:0010034) | 2.44007670 |
| 83 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.44007670 |
| 84 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.40556063 |
| 85 | Prostate neoplasm (HP:0100787) | 2.40045230 |
| 86 | Hematochezia (HP:0002573) | 2.39824461 |
| 87 | Frequent falls (HP:0002359) | 2.38651511 |
| 88 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.38651061 |
| 89 | Absent/shortened dynein arms (HP:0200106) | 2.38651061 |
| 90 | Congenital sensorineural hearing impairment (HP:0008527) | 2.36867696 |
| 91 | Hamartoma of the eye (HP:0010568) | 2.36826425 |
| 92 | Focal motor seizures (HP:0011153) | 2.36218960 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.35637053 |
| 94 | Distal arthrogryposis (HP:0005684) | 2.31889124 |
| 95 | Fibular aplasia (HP:0002990) | 2.31722193 |
| 96 | Abnormality of renal resorption (HP:0011038) | 2.31639336 |
| 97 | Hypoplasia of the uterus (HP:0000013) | 2.31442847 |
| 98 | Round ear (HP:0100830) | 2.30485409 |
| 99 | Abnormal drinking behavior (HP:0030082) | 2.28945969 |
| 100 | Polydipsia (HP:0001959) | 2.28945969 |
| 101 | Hypoplasia of the ulna (HP:0003022) | 2.28207869 |
| 102 | Decreased central vision (HP:0007663) | 2.27862022 |
| 103 | * Ventricular arrhythmia (HP:0004308) | 2.27714192 |
| 104 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.26330041 |
| 105 | Disinhibition (HP:0000734) | 2.25642127 |
| 106 | Abnormality of macrophages (HP:0004311) | 2.25570194 |
| 107 | Mesomelia (HP:0003027) | 2.24488161 |
| 108 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.24163388 |
| 109 | Stomach cancer (HP:0012126) | 2.23047358 |
| 110 | Metabolic alkalosis (HP:0200114) | 2.22787882 |
| 111 | Pendular nystagmus (HP:0012043) | 2.22098440 |
| 112 | Atrioventricular block (HP:0001678) | 2.21905677 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 2.21365793 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19908956 |
| 115 | * Abnormal EKG (HP:0003115) | 2.19729352 |
| 116 | Facial diplegia (HP:0001349) | 2.19410631 |
| 117 | Hypoplastic ischia (HP:0003175) | 2.18786011 |
| 118 | Stenosis of the external auditory canal (HP:0000402) | 2.15990524 |
| 119 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.11685113 |
| 120 | Arterial tortuosity (HP:0005116) | 2.11582001 |
| 121 | Abnormality of the 1st metacarpal (HP:0010009) | 2.09885001 |
| 122 | Agitation (HP:0000713) | 2.09451208 |
| 123 | Hypoplasia of the iris (HP:0007676) | 2.08736242 |
| 124 | Abnormality of renal excretion (HP:0011036) | 2.07384782 |
| 125 | Abnormality of secondary sexual hair (HP:0009888) | 2.07247013 |
| 126 | Abnormality of the axillary hair (HP:0100134) | 2.07247013 |
| 127 | Short tibia (HP:0005736) | 2.07023696 |
| 128 | Gaze-evoked nystagmus (HP:0000640) | 2.06490876 |
| 129 | Short 4th metacarpal (HP:0010044) | 2.04190509 |
| 130 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.04190509 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 2.04178672 |
| 132 | Optic neuritis (HP:0100653) | 2.04178672 |
| 133 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.03870758 |
| 134 | Oral leukoplakia (HP:0002745) | 2.03749429 |
| 135 | Left ventricular hypertrophy (HP:0001712) | 2.01573151 |
| 136 | Neck muscle weakness (HP:0000467) | 2.01458937 |
| 137 | Medial flaring of the eyebrow (HP:0010747) | 2.00942826 |
| 138 | Abnormality of the renal collecting system (HP:0004742) | 2.00008783 |
| 139 | Male pseudohermaphroditism (HP:0000037) | 1.99570582 |
| 140 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.99228377 |
| 141 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.99228377 |
| 142 | * Scapular winging (HP:0003691) | 1.98615733 |
| 143 | Foot dorsiflexor weakness (HP:0009027) | 1.97906063 |
| 144 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.97802805 |
| 145 | Bone cyst (HP:0012062) | 1.97399003 |
| 146 | Goiter (HP:0000853) | 1.95878866 |
| 147 | Ventricular fibrillation (HP:0001663) | 1.94045856 |
| 148 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93775520 |
| 149 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93775520 |
| 150 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93775520 |
| 151 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.93146169 |
| 152 | Abnormality of the nasal septum (HP:0000419) | 1.90832104 |
| 153 | Gowers sign (HP:0003391) | 1.89145180 |
| 154 | Abnormality of DNA repair (HP:0003254) | 1.88673221 |
| 155 | Mediastinal lymphadenopathy (HP:0100721) | 1.88071179 |
| 156 | Methylmalonic acidemia (HP:0002912) | 1.87944045 |
| 157 | Inappropriate behavior (HP:0000719) | 1.87927237 |
| 158 | Attenuation of retinal blood vessels (HP:0007843) | 1.87122707 |
| 159 | Abnormality of renin-angiotensin system (HP:0000847) | 1.87019135 |
| 160 | Systemic lupus erythematosus (HP:0002725) | 1.86521480 |
| 161 | Chronic hepatic failure (HP:0100626) | 1.86487841 |
| 162 | Abnormality of the ischium (HP:0003174) | 1.86201807 |
| 163 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.85275797 |
| 164 | Vascular calcification (HP:0004934) | 1.85195553 |
| 165 | Abnormality of the foot musculature (HP:0001436) | 1.84707674 |
| 166 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84518046 |
| 167 | Cystic liver disease (HP:0006706) | 1.84078863 |
| 168 | Muscular dystrophy (HP:0003560) | 1.84063905 |
| 169 | Gingivitis (HP:0000230) | 1.83601615 |
| 170 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83549911 |
| 171 | Hyperkalemia (HP:0002153) | 1.82622112 |
| 172 | Cerebral aneurysm (HP:0004944) | 1.81703520 |
| 173 | Abnormal ciliary motility (HP:0012262) | 1.80802054 |
| 174 | Radial bowing (HP:0002986) | 1.80544707 |
| 175 | Vascular tortuosity (HP:0004948) | 1.80513640 |
| 176 | Abnormality of the right ventricle (HP:0001707) | 1.80242922 |
| 177 | Limb dystonia (HP:0002451) | 1.79407166 |
| 178 | Sudden cardiac death (HP:0001645) | 1.79194673 |
| 179 | Polyuria (HP:0000103) | 1.76555278 |
| 180 | Neurofibrillary tangles (HP:0002185) | 1.75435955 |
| 181 | Tubular atrophy (HP:0000092) | 1.75368877 |
| 182 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75047514 |
| 183 | Onion bulb formation (HP:0003383) | 1.74847397 |
| 184 | IgG deficiency (HP:0004315) | 1.74784299 |
| 185 | Renal cortical cysts (HP:0000803) | 1.74495328 |
| 186 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.73596806 |
| 187 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.73596806 |
| 188 | Rhabdomyolysis (HP:0003201) | 1.73462019 |
| 189 | Difficulty climbing stairs (HP:0003551) | 1.72607941 |
| 190 | Bell-shaped thorax (HP:0001591) | 1.70378859 |
| 191 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.68867427 |
| 192 | Broad-based gait (HP:0002136) | 1.67925952 |
| 193 | Rapidly progressive (HP:0003678) | 1.61438379 |
| 194 | Generalized muscle weakness (HP:0003324) | 1.60259332 |
| 195 | Progressive visual loss (HP:0000529) | 1.59901809 |
| 196 | Stomatitis (HP:0010280) | 1.58736674 |
| 197 | Febrile seizures (HP:0002373) | 1.57454308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.21527097 |
| 2 | TTN | 3.77362187 |
| 3 | OBSCN | 3.76295644 |
| 4 | TLK1 | 3.63107783 |
| 5 | BLK | 3.06576173 |
| 6 | TAOK3 | 2.84431898 |
| 7 | PHKG2 | 2.76948267 |
| 8 | PHKG1 | 2.76948267 |
| 9 | ADRBK2 | 2.58760279 |
| 10 | RIPK4 | 2.48599616 |
| 11 | TGFBR2 | 2.46204248 |
| 12 | EPHA4 | 2.43847649 |
| 13 | BMPR1B | 2.23947728 |
| 14 | GRK7 | 2.14572275 |
| 15 | ACVR1B | 2.13688535 |
| 16 | DMPK | 2.11549992 |
| 17 | TXK | 1.91443434 |
| 18 | PIK3CA | 1.80067832 |
| 19 | TRPM7 | 1.78903603 |
| 20 | AKT3 | 1.68754181 |
| 21 | WNK4 | 1.61223365 |
| 22 | EPHB1 | 1.59471674 |
| 23 | DAPK2 | 1.48291052 |
| 24 | CAMK1D | 1.40622752 |
| 25 | PDK2 | 1.37871937 |
| 26 | PRPF4B | 1.35395405 |
| 27 | CAMK1G | 1.33195155 |
| 28 | MAPK13 | 1.31557162 |
| 29 | INSRR | 1.29767419 |
| 30 | PINK1 | 1.27776133 |
| 31 | LMTK2 | 1.25474357 |
| 32 | MAPK12 | 1.25202062 |
| 33 | TNIK | 1.22394269 |
| 34 | PIK3CG | 1.21111014 |
| 35 | RIPK1 | 1.17947770 |
| 36 | IKBKB | 1.12661845 |
| 37 | MAP2K4 | 1.11076893 |
| 38 | PKN1 | 1.10147561 |
| 39 | CSK | 1.10147237 |
| 40 | CASK | 1.08555656 |
| 41 | PDPK1 | 1.06517598 |
| 42 | TEC | 1.05287984 |
| 43 | STK39 | 1.04988758 |
| 44 | BMPR2 | 1.04950225 |
| 45 | ADRBK1 | 1.04211671 |
| 46 | SYK | 1.03320646 |
| 47 | MAPK7 | 1.00962904 |
| 48 | RPS6KA6 | 1.00216102 |
| 49 | SGK3 | 0.99700526 |
| 50 | CAMK2D | 0.99388577 |
| 51 | SGK2 | 0.98134969 |
| 52 | MAP3K14 | 0.95407298 |
| 53 | PRKCE | 0.94219770 |
| 54 | TRIB3 | 0.94049248 |
| 55 | TAF1 | 0.93587130 |
| 56 | PRKD1 | 0.92629736 |
| 57 | ERBB3 | 0.92577142 |
| 58 | STK16 | 0.92523871 |
| 59 | GRK6 | 0.91357265 |
| 60 | WNK3 | 0.91161431 |
| 61 | CAMK4 | 0.89500247 |
| 62 | JAK1 | 0.88715385 |
| 63 | RPS6KA2 | 0.88284452 |
| 64 | PRKCH | 0.88223508 |
| 65 | GRK5 | 0.87879955 |
| 66 | NTRK3 | 0.87842063 |
| 67 | ITK | 0.86772737 |
| 68 | PDK4 | 0.84630649 |
| 69 | PDK3 | 0.84630649 |
| 70 | STK24 | 0.84054252 |
| 71 | STK11 | 0.83722598 |
| 72 | PRKD2 | 0.83470676 |
| 73 | SGK223 | 0.81536508 |
| 74 | SGK494 | 0.81536508 |
| 75 | CAMKK2 | 0.80876420 |
| 76 | MAP3K2 | 0.79624155 |
| 77 | MAP3K13 | 0.79458085 |
| 78 | PRKAA2 | 0.79032793 |
| 79 | LYN | 0.78311969 |
| 80 | FGR | 0.77231846 |
| 81 | SGK1 | 0.76641109 |
| 82 | OXSR1 | 0.75336567 |
| 83 | MAP3K4 | 0.74779207 |
| 84 | RPS6KC1 | 0.72652305 |
| 85 | RPS6KL1 | 0.72652305 |
| 86 | PRKCG | 0.72465790 |
| 87 | MAP3K7 | 0.71481432 |
| 88 | PLK2 | 0.71333875 |
| 89 | PDK1 | 0.71174159 |
| 90 | CAMK2A | 0.71143864 |
| 91 | ZAK | 0.70965857 |
| 92 | MAP2K6 | 0.70595284 |
| 93 | EPHA3 | 0.69413548 |
| 94 | CAMK1 | 0.69367855 |
| 95 | FGFR2 | 0.68727318 |
| 96 | NTRK2 | 0.66981972 |
| 97 | MAP2K7 | 0.66916036 |
| 98 | MAP4K2 | 0.62880173 |
| 99 | MYLK | 0.62307208 |
| 100 | FRK | 0.61247821 |
| 101 | TNK2 | 0.61099286 |
| 102 | NLK | 0.61028840 |
| 103 | MAPKAPK5 | 0.60982872 |
| 104 | WNK1 | 0.60883459 |
| 105 | MATK | 0.60788111 |
| 106 | BMX | 0.60023476 |
| 107 | PDGFRB | 0.59960092 |
| 108 | * PRKACA | 0.59557909 |
| 109 | FES | 0.58146843 |
| 110 | HCK | 0.57806852 |
| 111 | KIT | 0.57737983 |
| 112 | IRAK4 | 0.56780633 |
| 113 | IRAK1 | 0.53969482 |
| 114 | CDK5 | 0.53927241 |
| 115 | NEK9 | 0.53452242 |
| 116 | PIM1 | 0.52647376 |
| 117 | BTK | 0.52114528 |
| 118 | NUAK1 | 0.51467686 |
| 119 | PAK3 | 0.51310999 |
| 120 | ERBB2 | 0.50067906 |
| 121 | CAMK2B | 0.49906398 |
| 122 | IRAK3 | 0.48187611 |
| 123 | SIK2 | 0.48083055 |
| 124 | FYN | 0.46970676 |
| 125 | CAMKK1 | 0.46961610 |
| 126 | PRKG1 | 0.46841376 |
| 127 | FGFR3 | 0.46515981 |
| 128 | LCK | 0.45594924 |
| 129 | TBK1 | 0.45576234 |
| 130 | PNCK | 0.45477983 |
| 131 | CAMK2G | 0.45164806 |
| 132 | CHUK | 0.45161229 |
| 133 | EGFR | 0.45030250 |
| 134 | DYRK3 | 0.44061971 |
| 135 | DYRK2 | 0.43878875 |
| 136 | ZAP70 | 0.43504965 |
| 137 | KDR | 0.43184614 |
| 138 | GRK1 | 0.42206230 |
| 139 | MAP3K9 | 0.42204249 |
| 140 | MUSK | 0.41702570 |
| 141 | NME1 | 0.41364535 |
| 142 | PRKACG | 0.41259940 |
| 143 | PTK2B | 0.40403374 |
| 144 | PRKCQ | 0.39569769 |
| 145 | HIPK2 | 0.38700601 |
| 146 | CLK1 | 0.38115108 |
| 147 | PRKCZ | 0.36810202 |
| 148 | MARK2 | 0.35900341 |
| 149 | NTRK1 | 0.34944076 |
| 150 | YES1 | 0.32841146 |
| 151 | IKBKE | 0.32232354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.38411684 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.25063035 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.11146873 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96687623 |
| 5 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.95308026 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 1.90982430 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84690493 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81416212 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73769684 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.69428285 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60610800 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59995365 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.54820575 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51844936 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42311800 |
| 16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41399613 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.39137839 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38566074 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37470612 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36263368 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30100271 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29925652 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.29205814 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29131885 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.28348737 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28347263 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28337357 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.27129664 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26572733 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24674780 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.22957998 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22146320 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.21805387 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.20964693 |
| 35 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20579733 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20058899 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16249941 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16138212 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12605590 |
| 40 | * Renin secretion_Homo sapiens_hsa04924 | 1.12353280 |
| 41 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.10307665 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.09554095 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06544215 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06247420 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05593817 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.05285802 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.05155044 |
| 48 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.05066776 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04289549 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04019523 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.02924341 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01425885 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01280099 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99635874 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99549791 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99192924 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98961881 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98719748 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98063934 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97960527 |
| 61 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97602398 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96118335 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.94672681 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94454266 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.94075269 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93800885 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93275736 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93135936 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92281695 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92019485 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.91458984 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.90122730 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89526631 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88748618 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88519925 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87807747 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87561088 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.87357249 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86583802 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85811381 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84990530 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83926425 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83569069 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.83281957 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83153553 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.81611769 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.81502087 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80259940 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80116388 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79984701 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77940420 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77459521 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77126835 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76614162 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75951804 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75328796 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74625932 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73569987 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73181225 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73014247 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.72310348 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72156156 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70595131 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70559130 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.70459231 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.69516558 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69208403 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69039653 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.68243532 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68227287 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68116722 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67765173 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67696026 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67275230 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67161609 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67045522 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66943371 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66340709 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65875733 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65862732 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65789816 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65561865 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.64763804 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64639469 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63339175 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63108378 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61396984 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60952244 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59512386 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.59137923 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.59120892 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59113076 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59108537 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59102785 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58976891 |
| 136 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58781728 |
| 137 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58523056 |
| 138 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58123158 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58073318 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57610426 |
| 141 | Long-term depression_Homo sapiens_hsa04730 | 0.57160489 |
| 142 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57101329 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56411382 |
| 144 | Melanoma_Homo sapiens_hsa05218 | 0.55438492 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54162829 |
| 146 | Gap junction_Homo sapiens_hsa04540 | 0.53339756 |
| 147 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51526780 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50780583 |
| 149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49948541 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49221550 |
| 151 | Ribosome_Homo sapiens_hsa03010 | 0.48465303 |

